hg_120044.1

Basic information about the TSS

---

TSS ID: hg_120044.1 Species: human Chr: chr11		Start: 61829281 End: 61829293 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000448607.1 Distance: -16 GeneID: 3992 HGNC/MGI_ID: HGNC:3574 UniProt_ID: C9J425

Gene_name: fatty acid desaturase 1 Gene_symbol: FADS1 Gene_synonyms: D5D FADS6 FADSD5 TU12 Gene_source: HGNC:3574

TATA-Box annotation

---

Distance to TSS:	987
Nearest PromoterID:	NM_004265
Entrez ID:	9415
Nearest Unigene:	Hs.502745
Nearest Refseq:	NM_004265
Nearest Ensembl:	ENSG00000134824
Gene Name:	fatty acid desaturase 1
Gene Alias:	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13
Gene Description:	fatty acid desaturase 2
Gene Type:	protein-coding
CpG%:	0.06
GC%:	0.59204
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@FADS1 p2@FADS1 p4@FADS1 p5@FADS1 p7@FADS1 p8@FADS1
Sample		p1@FADS1	p2@FADS1	p4@FADS1	p5@FADS1	p7@FADS1	p8@FADS1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.14	8.38	1.95	1.95	0.19	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.22	10.52	4.45	4.65	0.20	2.02
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	17.17	9.07	2.31	4.44	0.19	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	14.35	6.86	3.53	2.91	0.21	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.82	9.67	1.12	3.37	0.45	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.41	8.33	2.33	3.29	0.00	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.94	12.42	4.14	5.01	0.22	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	13.08	6.54	2.18	2.18	0.24	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.68	10.04	2.78	3.42	0.00	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	7.54	7.54	3.48	0.58	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.49	5.26	4.85	2.02	0.00	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.91	8.94	3.25	2.85	0.41	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.09	2.58	2.10	1.77	0.48	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.78	2.56	2.26	2.71	0.60	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.51	2.63	2.85	0.66	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.84	1.26	2.01	1.26	0.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.58	3.06	3.28	1.09	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	12.23	2.53	3.37	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.00	2.67	1.60	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.33	1.05	2.41	2.11	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.70	3.34	1.47	1.20	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	11.22	2.24	1.21	2.07	0.17	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.44	2.97	1.94	1.81	0.39	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.25	1.46	0.97	1.70	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.35	3.10	1.81	2.06	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.44	0.95	1.58	1.27	0.95	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.19	4.40	2.20	1.10	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.15	4.01	2.36	1.41	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.98	2.10	0.81	0.81	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	8.87	1.81	1.99	1.27	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.63	2.30	1.88	1.26	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.55	2.74	3.13	0.78	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.14	1.90	1.06	1.48	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.73	2.14	2.47	1.15	0.33	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.79	1.31	1.31	1.12	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.35	1.34	2.11	0.77	0.57	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.38	1.23	1.64	1.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.28	1.81	1.81	2.22	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.61	1.35	2.97	1.08	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.56	1.20	1.44	0.24	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.88	2.35	1.65	1.41	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.52	2.49	0.73	1.02	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	9.28	2.11	0.63	1.48	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.14	1.57	1.75	1.22	0.35	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	10.24	1.61	1.41	1.00	1.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.47	1.40	2.79	1.40	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.76	1.92	0.96	1.20	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.43	2.09	0.89	1.19	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	12.45	1.91	2.15	1.68	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.71	2.22	1.01	0.40	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.40	2.66	1.23	1.02	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.46	4.89	1.78	2.67	0.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.26	3.19	1.42	1.42	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.23	1.99	2.32	0.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	2.52	0.84	0.00	0.84	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.27	1.84	0.00	1.38	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.53	2.59	2.92	1.94	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.66	3.21	2.89	1.61	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	6.29	1.26	1.57	0.63	0.31	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	23.27	4.94	2.82	2.82	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	32.53	3.36	3.93	4.49	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	3.98	2.39	0.80	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.03	2.38	1.36	1.36	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.84	4.22	6.17	2.60	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	39.05	5.68	4.61	1.06	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	106.28	8.78	4.39	4.39	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	111.57	6.94	4.96	2.98	1.98	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	87.72	7.97	10.32	3.28	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	70.87	7.95	4.97	0.99	2.32	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	127.45	10.21	8.97	2.47	1.86	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	151.65	8.26	10.40	3.36	0.61	2.14
Adipocyte - breast, donor1	11376-118A8	88.54	4.28	1.43	2.22	0.63	1.27
Adipocyte - breast, donor2	11327-117E4	659.35	5.94	0.96	3.05	0.64	1.28
Adipocyte - omental, donor1	11473-119C6	217.30	10.31	1.78	4.07	3.18	1.02
Adipocyte - omental, donor2	11474-119C7	88.95	6.73	2.99	2.24	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	236.12	8.71	2.34	1.34	2.68	1.00
Adipocyte - perirenal, donor1	11476-119C9	55.51	5.74	1.91	0.64	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	303.46	5.50	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	469.69	7.68	1.35	2.71	1.35	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	564.77	5.73	0.35	2.95	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	506.92	11.54	1.96	7.63	1.37	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	236.27	11.84	1.03	2.57	1.03	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	430.70	19.24	3.35	5.02	2.23	2.23
Adipocyte differentiation, day04, donor4	13028-139E4	539.61	14.11	2.35	4.11	0.59	2.94
Adipocyte differentiation, day08, donor1	13020-139D5	785.27	17.61	0.64	10.46	1.53	2.17
Adipocyte differentiation, day08, donor2	13023-139D8	339.54	11.30	0.65	5.49	0.97	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	288.99	9.60	1.60	1.60	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	549.20	12.80	0.56	5.01	1.11	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	1419.44	14.97	0.42	2.08	1.66	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	476.46	10.30	0.50	3.27	1.26	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	839.71	7.20	0.98	3.60	2.62	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	1147.25	7.00	0.00	3.04	0.30	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	31.82	7.73	1.33	1.77	0.22	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	17.93	5.02	0.72	1.43	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	17.97	2.40	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	43.36	6.30	3.24	1.26	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	3.35	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	28.76	3.29	2.67	0.82	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	97.95	7.44	0.46	2.63	2.40	0.57
Anulus Pulposus Cell, donor2	11463-119B5	60.98	3.43	0.98	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.97	0.90	0.00	1.35	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	2.17	0.43	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	18.83	1.49	1.79	0.30	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	2.53	1.26	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	0.00	1.32	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.97	1.30	1.95	0.32	1.30	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.53	0.97	0.97	0.00	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	9.50	0.59	0.00	0.59	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.81	1.88	0.75	0.38	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	0.73	2.90	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.52	1.98	0.66	0.99	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	2.73	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.46	1.36	0.90	0.60	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	13.39	1.61	2.68	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.74	1.32	1.32	0.76	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.84	2.67	1.34	0.27	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	2.93	0.98	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	12.44	0.66	0.66	0.17	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	0.00	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.38	1.20	1.20	0.17	0.34	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.62	1.94	0.97	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.14	2.28	1.14	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	1.21	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.11	1.14	0.00	0.00	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.89	1.71	1.71	0.43	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.87	1.29	0.77	0.52	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.26	0.47	0.94	0.00	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	12.22	0.64	3.22	0.64	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.99	1.43	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.19	1.75	1.17	2.34	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.24	0.30	0.90	0.00	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	10.68	1.53	2.54	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.19	0.25	2.04	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	0.64	0.64	0.64	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	0.43	2.59	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.01	1.48	1.48	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.57	0.87	0.58	0.29	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	0.94	0.94	0.94	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.98	1.36	0.34	0.68	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	0.00	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.15	3.00	0.43	0.64	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	1.80	1.20	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.87	0.92	1.61	0.92	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.63	0.51	0.76	0.51	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	12.18	2.27	0.62	1.03	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.85	1.22	2.14	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	1.91	1.43	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.74	1.55	1.55	0.89	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	1.66	0.55	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.06	1.06	1.59	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	1.09	0.36	1.09	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	81.92	15.47	3.68	2.09	3.32	4.79
Astrocyte - cerebellum, donor2	11580-120F5	52.89	8.22	2.74	3.25	2.40	2.57
Astrocyte - cerebellum, donor3	11661-122F5	31.46	6.08	1.05	2.94	1.26	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	57.52	11.85	2.09	8.37	3.49	4.18
Astrocyte - cerebral cortex, donor2	11316-117D2	56.94	14.88	3.72	9.22	2.10	3.24
Astrocyte - cerebral cortex, donor3	11392-118C6	92.48	18.94	4.18	10.14	3.88	4.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	17.89	3.67	4.82	1.26	7.68	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	13.66	3.51	2.88	0.63	6.39	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	16.50	2.28	1.82	1.59	5.80	0.34
Basophils, donor1	12241-129G9	1.83	0.52	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	3.61	0.36	0.36	0.00	0.00	0.00
Basophils, donor3	12243-129H2	9.11	1.32	0.44	0.15	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	6.68	1.08	0.43	0.22	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	14.63	0.00	0.91	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.08	2.51	0.00	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	44.92	6.24	1.25	0.62	0.21	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	31.55	2.76	1.38	0.46	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	33.65	2.34	2.16	0.54	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.89	0.47	1.63	0.93	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	14.71	4.48	4.48	2.24	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.71	1.69	2.25	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	10.58	2.04	1.30	0.00	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	7.68	0.88	0.44	0.22	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.74	3.40	2.55	1.13	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.47	1.52	3.03	0.38	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	36.49	3.29	0.99	1.97	1.64	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	7.66	2.02	0.58	0.00	0.43	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	7.24	0.00	0.00	0.00	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	4.03	0.47	0.24	0.47	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.69	1.34	0.33	0.00	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.14	0.55	0.55	0.00	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.73	1.49	0.25	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.44	1.57	0.00	0.00	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.16	0.71	0.18	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.01	1.74	0.22	0.22	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.49	1.87	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.45	2.64	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	1.11	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.84	0.89	0.15	0.00	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.59	1.00	0.20	0.00	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1.67	0.83	0.21	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.26	1.37	0.23	0.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.43	1.13	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	0.87	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.38	1.88	0.54	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.36	1.57	0.70	0.52	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.47	0.00	0.84	0.00	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	7.72	1.29	0.37	0.55	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.93	1.41	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	0.44	0.44	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.58	1.57	0.52	0.35	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.20	3.35	0.37	0.37	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.39	2.37	0.00	0.22	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.78	2.46	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.01	0.70	0.23	0.46	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.94	0.70	0.23	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	10.24	0.87	1.53	0.22	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	8.32	1.39	0.46	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	6.93	1.08	0.65	0.00	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	16.04	3.43	1.09	0.47	0.62	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	10.48	1.57	0.87	0.35	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	7.80	1.11	0.45	0.22	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	3.32	0.26	0.51	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	5.27	0.22	0.00	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	2.95	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1.07	0.53	0.53	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1.61	0.00	0.00	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	1.40	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2.47	0.00	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.73	0.00	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.50	0.50	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	31.92	2.83	2.02	1.21	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.97	2.00	1.60	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	21.09	5.02	5.02	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	10.11	3.93	2.81	0.56	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	21.04	4.51	3.01	2.25	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	17.14	6.54	4.06	2.03	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	0.71	0.00	0.36	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	1.22	0.00	0.61	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	0.00	0.30	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2.55	0.51	3.57	0.51	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2.92	0.22	3.37	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1.15	0.00	3.16	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.47	0.00	2.37	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	0.00	2.11	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.17	0.43	2.46	0.58	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	3.05	0.00	2.20	0.00	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	2.10	0.32	1.29	0.00	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.00	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.44	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	6.75	0.42	2.95	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	6.23	0.42	2.29	0.21	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	10.02	0.67	3.34	0.33	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1.09	0.00	2.72	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.54	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.06	2.23	8.72	0.00	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	2.82	0.87	2.60	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	3.99	0.84	2.10	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	3.03	0.51	2.02	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.44	0.00	0.87	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.49	0.00	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.92	0.00	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1.94	0.83	1.66	0.00	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1.96	0.49	0.98	0.25	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1.54	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.72	0.00	0.72	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.65	0.00	0.65	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.76	0.50	0.50	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	46.34	6.65	7.57	3.21	2.52	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	47.45	7.91	9.35	2.40	2.88	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	44.60	8.75	6.02	5.20	2.74	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	30.32	4.80	4.50	3.90	1.50	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	30.24	7.20	5.04	2.64	2.88	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.97	4.55	5.91	2.27	1.59	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.23	13.47	7.82	7.82	3.91	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	65.01	18.16	10.00	6.58	2.63	3.42
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	60.50	11.26	8.68	6.33	2.11	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	69.13	12.08	10.57	6.34	5.13	4.23
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	70.59	14.23	7.26	5.81	2.03	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	57.82	12.52	9.33	3.20	2.93	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	60.85	13.57	12.69	2.63	3.50	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	57.38	12.30	14.12	2.73	3.19	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	66.38	9.70	8.20	2.98	0.75	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	21.25	6.12	6.12	1.44	1.80	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	25.32	5.75	6.91	3.16	0.00	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.51	6.60	2.83	1.89	1.41	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	47.85	11.73	5.70	3.49	1.58	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	46.75	13.53	4.61	4.00	1.54	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	42.96	13.79	7.05	3.53	0.96	2.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	44.75	11.86	6.88	5.74	1.91	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	48.08	14.19	7.49	5.12	4.73	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	40.85	8.32	6.81	3.78	3.03	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.88	4.01	3.21	0.80	2.41	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.08	5.60	3.50	0.00	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	25.04	7.01	14.02	1.00	8.01	1.00
Cardiac Myocyte, donor1	11525-119I4	54.83	5.48	0.00	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	41.50	4.45	0.49	1.98	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	52.72	4.21	1.37	1.89	0.63	0.74
Chondrocyte - de diff, donor1	11261-116G1	13.87	3.81	0.69	0.00	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	8.88	1.78	0.36	0.00	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	10.47	0.91	0.57	0.91	0.46	0.11
Chondrocyte - re diff, donor2	11339-117F7	32.23	5.37	2.69	0.00	5.37	1.79
Chondrocyte - re diff, donor3	11411-118E7	19.01	0.81	1.21	1.21	1.62	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	130.25	23.87	3.21	11.82	3.56	5.74
Ciliary Epithelial Cells, donor2	11323-117D9	73.75	13.68	1.92	5.77	3.63	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	123.54	15.04	2.12	6.90	2.39	3.10
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	34.94	3.67	2.57	1.38	0.92	1.28
Corneal Epithelial Cells, donor1	11526-119I5	18.22	2.20	0.66	0.22	0.22	0.44
Corneal Epithelial Cells, donor2	11606-120I4	20.48	3.41	2.28	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	23.01	3.83	1.79	1.28	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	20.31	1.65	1.65	0.33	0.99	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.02	1.58	1.58	0.63	1.26	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	3.45	10.35	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	46.33	4.43	1.84	0.97	1.08	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	30.06	13.67	2.39	0.68	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	19.59	7.83	0.00	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.49	11.61	1.45	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	30.35	5.50	3.34	2.00	1.50	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	4.11	0.59	2.93	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	25.45	6.22	2.26	1.70	0.85	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	10.62	2.75	1.18	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	5.53	0.58	1.45	0.00	1.75	0.00
Endothelial Cells - Artery, donor2	11341-117F9	14.82	4.47	2.59	1.65	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	12.97	2.45	1.58	0.70	0.70	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	13.30	3.55	1.99	1.11	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.95	3.35	1.22	0.61	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.10	3.38	3.10	0.28	0.28	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	17.53	4.75	2.67	0.89	0.30	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	3.64	2.60	0.00	0.00	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	6.38	0.99	0.99	0.28	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	19.21	5.20	2.00	0.80	1.20	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	1.57	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	46.72	10.93	3.48	3.48	2.98	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	37.80	7.60	2.82	3.48	0.87	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	53.61	10.63	4.40	2.44	1.22	1.71
Endothelial Cells - Vein, donor1	11267-116G7	21.61	5.69	4.55	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	31.43	4.19	0.70	4.19	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	21.35	5.02	2.83	1.73	0.94	0.63
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	24.19	4.15	0.98	0.49	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.70	1.23	1.23	1.23	2.05	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	25.95	1.42	0.66	0.44	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.13	0.98	0.54	0.76	0.76	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.37	2.79	0.73	2.18	0.85	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	34.25	2.46	0.68	1.23	0.14	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	60.64	4.01	0.63	1.37	0.84	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	67.19	5.27	4.48	1.05	2.37	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	28.24	3.65	2.66	1.33	1.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	21.77	2.27	0.45	0.91	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.92	2.27	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.67	1.73	1.26	0.47	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	86.39	9.09	1.52	4.85	1.21	1.52
Fibroblast - Cardiac, donor5	11456-119A7	60.28	7.36	1.78	2.03	1.65	0.89
Fibroblast - Cardiac, donor6	11460-119B2	66.09	10.16	3.49	1.36	0.91	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	321.04	30.42	4.02	3.75	2.55	6.30
Fibroblast - Choroid Plexus, donor2	11572-120E6	141.08	18.55	3.02	3.45	0.43	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	152.34	8.79	5.86	4.39	1.46	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	121.09	11.99	6.92	4.84	1.15	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	254.24	12.04	1.70	5.77	1.70	1.02
Fibroblast - Dermal, donor1	11269-116G9	86.87	5.87	1.41	1.64	0.94	0.00
Fibroblast - Dermal, donor2	11346-117G5	58.02	6.60	2.36	3.77	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	112.18	6.53	1.69	2.66	1.09	0.48
Fibroblast - Dermal, donor4	11450-119A1	147.98	13.90	2.49	2.83	1.92	1.70
Fibroblast - Dermal, donor5	11454-119A5	142.70	19.71	2.79	3.49	1.74	1.40
Fibroblast - Dermal, donor6	11458-119A9	142.12	22.09	3.74	3.74	1.30	1.79
Fibroblast - Gingival, donor1	11237-116D4	265.08	11.66	1.46	4.58	1.46	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	13.10	1.57	1.05	0.52	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	123.61	17.53	1.58	5.93	1.98	1.58
Fibroblast - Gingival, donor3	11394-118C8	256.70	13.83	1.26	6.48	2.32	1.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	161.03	14.54	1.04	3.12	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	79.64	7.05	0.70	3.00	0.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	33.99	7.33	1.40	1.40	0.94	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	43.27	6.36	0.41	2.43	1.76	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.94	5.65	2.12	1.06	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	59.08	8.04	1.32	2.34	2.49	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	33.54	8.18	1.09	2.18	3.27	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.12	8.23	1.21	2.30	1.76	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	51.95	3.52	1.32	1.76	1.32	0.59
Fibroblast - Lung, donor1	11270-116H1	47.58	4.08	4.08	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	53.72	2.98	4.48	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	69.85	9.50	0.63	4.43	1.90	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	224.92	11.66	2.50	2.50	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	162.24	6.99	1.40	1.40	1.40	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	61.85	2.80	1.12	0.56	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	241.96	19.49	5.28	4.06	1.62	2.44
Fibroblast - Mammary, donor2	11620-122A9	63.91	3.99	3.99	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	95.30	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	144.90	16.10	2.13	5.43	1.55	2.52
Fibroblast - Periodontal Ligament, donor2	11319-117D5	147.89	22.90	3.19	7.28	1.06	2.12
Fibroblast - Periodontal Ligament, donor3	11395-118C9	238.06	16.22	1.22	5.51	2.14	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	51.90	4.96	1.53	3.05	1.53	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.38	2.43	1.08	1.08	0.81	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	78.75	7.77	1.04	3.48	1.62	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	22.77	3.98	1.22	1.44	0.77	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	319.42	18.90	5.08	3.86	2.44	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	140.99	12.03	2.67	3.34	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	167.24	11.47	2.37	6.33	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	24.61	5.16	2.78	0.60	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.41	3.20	2.84	0.71	0.71	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	19.71	2.56	0.39	0.59	1.38	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	29.48	6.02	3.31	0.00	1.81	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	18.89	4.32	1.19	0.32	2.48	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	14.43	3.04	1.77	0.00	1.01	0.51
Fibroblast - skin normal, donor1	11553-120C5	22.64	2.79	0.82	0.98	2.30	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	16.84	2.41	2.01	0.60	0.20	0.60
Fibroblast - skin normal, donor2	11561-120D4	13.96	1.61	1.11	0.60	1.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	13.60	4.23	2.72	0.00	1.81	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.66	2.73	1.41	1.16	1.08	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	37.95	4.44	2.56	1.37	1.88	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	30.22	3.28	3.61	0.99	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.04	3.30	1.38	0.21	0.75	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	25.13	6.58	0.84	1.18	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.59	1.88	0.47	0.16	1.25	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	0.87	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.84	4.51	1.56	0.35	0.87	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	28.63	4.42	1.30	0.52	0.52	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	34.75	2.81	2.56	0.00	0.51	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	27.56	13.01	7.66	3.83	1.53	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	27.44	6.38	4.47	1.91	2.55	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	30.24	6.56	10.55	2.28	2.28	3.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	31.44	14.62	9.93	9.10	2.21	4.69
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	24.66	6.16	5.25	4.79	5.71	3.88
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	26.75	8.72	13.67	3.96	1.59	3.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	30.13	13.48	11.10	8.72	2.64	3.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.61	5.22	7.83	8.15	8.15	4.89
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	32.72	7.08	10.61	2.65	2.65	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	18.09	3.82	12.58	1.84	1.70	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.26	5.05	8.62	3.57	1.85	3.08
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.88	2.69	8.06	1.61	1.34	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	25.89	7.68	5.20	3.35	2.11	2.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	22.84	7.06	6.51	2.21	1.66	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.08	4.47	6.91	1.63	2.03	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	24.87	10.04	4.34	5.70	2.05	2.97
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	20.80	5.98	4.73	1.49	0.75	3.11
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.33	5.90	5.25	1.75	1.53	1.53
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.32	9.16	4.43	3.25	2.95	4.14
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.33	11.13	5.09	5.09	2.07	4.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.26	10.72	4.92	3.57	1.79	2.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	40.53	17.34	7.86	4.84	1.81	3.43
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	37.66	11.03	4.24	6.11	3.05	3.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	37.69	13.66	5.32	5.14	1.42	5.59
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	43.29	16.23	11.45	8.84	2.08	5.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.91	11.27	8.37	5.46	3.07	5.29
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.54	8.85	7.52	4.32	2.77	3.43
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.11	14.14	5.91	5.41	2.50	5.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.83	11.64	3.06	4.08	2.45	5.10
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	30.74	12.58	5.78	5.36	1.86	4.13
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	38.62	13.14	7.15	4.38	2.88	3.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	41.36	15.18	6.67	8.00	3.17	5.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	27.99	9.26	9.26	6.39	2.65	3.31
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.97	9.22	8.36	5.41	1.97	2.58
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	39.87	14.10	6.00	6.00	2.76	5.67
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.60	9.30	10.26	2.57	1.92	2.25
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	26.63	10.04	6.44	3.41	2.56	2.94
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	39.86	12.50	6.96	7.59	2.21	3.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	23.41	11.25	5.78	4.26	1.52	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	24.36	8.26	5.75	4.18	1.57	1.88
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.06	11.20	6.81	6.81	2.20	2.42
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	28.34	6.17	6.45	5.61	1.96	2.52
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.20	7.22	3.89	3.24	1.30	1.67
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.82	10.70	3.21	7.22	1.60	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	27.39	9.64	3.83	5.20	1.53	2.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	30.05	9.20	4.15	3.37	1.81	2.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	32.80	12.20	3.52	7.05	2.44	4.07
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	31.52	7.74	3.87	4.24	2.21	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	29.83	9.43	4.82	3.07	0.44	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	33.72	8.93	9.92	13.88	0.00	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	46.83	10.55	2.37	4.22	0.79	1.58
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	47.82	8.07	3.63	6.46	2.02	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	33.29	9.91	8.64	6.35	1.02	2.03
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	16.12	6.37	16.72	1.19	3.18	2.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	16.49	3.70	10.32	1.08	3.39	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	23.94	5.52	16.16	1.23	3.07	4.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	33.17	10.01	8.14	3.76	0.00	4.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	33.62	6.78	6.50	2.83	0.57	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	29.98	6.00	5.53	0.46	1.84	4.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	9.90	14.85	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	43.32	10.83	7.35	3.48	1.93	5.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	52.95	12.84	6.42	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	50.43	10.43	3.48	5.22	0.00	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	52.73	12.04	5.86	3.58	1.63	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	45.30	8.65	5.35	2.88	2.47	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	6.66	3.33	6.66	10.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	60.12	14.26	5.59	5.59	2.80	6.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	63.08	15.03	6.21	5.23	2.61	5.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	71.30	15.10	7.55	5.87	2.52	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	81.11	16.54	7.63	4.45	1.59	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	73.37	16.98	3.74	2.72	2.72	4.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	64.73	8.35	6.26	2.09	10.44	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	89.34	20.04	6.30	8.02	4.01	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	69.26	18.94	3.85	3.26	3.55	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	83.01	15.25	8.47	3.39	3.39	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	94.44	19.88	3.31	4.14	1.66	3.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	96.42	23.01	7.59	5.98	2.53	7.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	15.81	5.27	0.00	5.27	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	100.33	16.53	4.61	6.92	0.77	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	84.10	14.02	4.24	4.89	1.63	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	60.86	16.05	5.35	6.02	6.02	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	93.62	27.74	6.55	5.78	2.31	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	69.15	16.09	5.82	4.11	2.40	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	77.03	17.39	9.94	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	81.63	21.23	7.08	5.19	5.66	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	88.11	19.92	4.22	3.62	1.21	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	74.27	12.21	7.63	4.58	3.56	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	88.94	17.15	4.79	6.38	2.39	6.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	130.25	19.24	6.41	4.44	2.47	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	54.30	22.43	8.26	1.18	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	81.68	20.42	4.67	2.33	7.00	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	110.60	19.75	8.34	1.76	6.14	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	52.56	15.26	5.09	0.85	3.39	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	85.96	11.94	4.78	7.16	1.79	7.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	80.55	14.07	5.34	2.91	3.88	3.88
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	61.63	3.42	1.14	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	32.85	7.07	1.25	1.66	1.25	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	22.49	1.12	1.12	1.12	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	136.38	5.71	0.95	2.54	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	405.21	4.60	0.84	2.51	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	55.35	16.36	5.34	4.41	3.37	1.28
Hep-2 cells mock treated, biol_rep2	11899-125E9	60.94	15.02	3.88	5.40	1.86	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	76.90	10.47	5.46	5.23	3.41	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	57.17	14.10	4.26	5.79	2.19	2.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	60.39	12.89	4.51	4.73	3.65	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	62.22	11.41	5.17	4.31	2.15	2.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	59.16	17.19	4.98	3.61	2.49	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	65.02	12.52	3.77	3.60	2.74	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	69.52	10.57	3.20	2.56	1.92	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	18.47	7.83	3.36	1.68	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	31.16	3.90	2.16	1.30	0.87	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	5.29	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	150.61	16.93	1.06	2.12	1.41	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	72.65	6.54	2.18	0.73	0.73	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	137.25	11.54	2.10	3.67	1.22	1.22
Hepatocyte, donor1	11523-119I2	259.07	9.68	0.00	3.63	1.21	1.21
Hepatocyte, donor2	11603-120I1	91.57	11.85	1.08	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	27.00	5.52	1.23	1.84	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	26.76	13.71	1.31	1.96	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	142.10	18.00	5.77	5.59	1.75	2.10
Iris Pigment Epithelial Cells, donor1	11530-119I9	76.84	11.66	0.96	3.70	2.06	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	216.50	28.66	19.10	6.37	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	206.93	6.68	13.35	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	352.08	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	238.11	15.23	18.00	4.15	6.92	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	190.20	15.02	15.02	2.50	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	284.84	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	248.60	23.07	10.25	2.56	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	196.54	13.71	18.28	9.14	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	399.58	11.37	34.11	9.75	4.87	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	183.40	8.34	8.34	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	206.94	0.00	21.78	3.63	7.26	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	313.66	21.18	19.85	1.32	5.29	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	197.34	17.74	13.30	1.11	4.43	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	188.58	5.24	20.95	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	291.00	13.86	13.86	5.04	5.67	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	236.63	17.01	10.83	4.64	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	204.89	14.63	14.63	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	310.10	21.97	15.50	2.58	7.11	4.52
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	246.32	4.83	19.32	4.83	4.83	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	238.96	47.79	23.90	0.00	35.84	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	333.29	24.45	16.30	4.89	3.26	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	240.97	20.99	14.27	3.36	4.62	2.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	258.70	0.00	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	376.12	22.50	26.52	3.21	6.43	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	228.05	10.16	8.31	5.54	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	241.29	0.00	30.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	346.48	21.24	11.33	4.72	2.83	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	207.70	15.42	8.16	1.81	3.63	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	250.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	445.51	18.29	13.99	8.61	2.15	5.38
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	271.88	17.79	16.52	6.35	5.08	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	343.07	17.22	10.84	3.83	5.74	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	253.35	14.58	14.58	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	173.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	341.32	23.56	21.42	2.86	1.43	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	212.37	13.27	16.59	9.95	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	312.98	14.51	9.88	4.63	2.78	3.40
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	210.72	22.83	12.29	0.00	3.51	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	163.44	12.57	31.43	0.00	6.29	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	278.85	16.69	11.82	4.17	4.87	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	148.28	15.49	13.28	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	220.46	19.45	19.45	0.00	0.00	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	152.59	14.82	16.57	3.49	2.62	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	62.99	9.00	24.75	2.25	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	108.02	17.42	27.88	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	94.94	4.27	12.80	5.33	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	211.97	12.47	16.63	1.39	8.31	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	225.12	14.25	17.10	2.85	5.70	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	238.39	10.12	12.89	5.52	4.60	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	54.46	6.05	18.15	3.03	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	12.42	24.83	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	52.87	7.40	16.92	3.17	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	35.41	3.26	0.82	0.49	0.33	0.41
Keratinocyte - epidermal, donor2	11349-117G8	7.61	1.17	1.17	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	22.81	3.22	1.99	0.95	0.38	0.19
Keratinocyte - oral, donor1	11251-116E9	18.96	3.29	2.61	0.45	0.11	0.34
Keratocytes, donor1	11527-119I6	28.54	7.56	2.41	3.78	1.38	0.00
Keratocytes, donor2	11607-120I5	222.64	11.72	4.69	5.86	1.17	0.00
Keratocytes, donor3	11688-122I5	89.91	8.30	1.58	2.37	1.78	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	55.02	12.94	2.16	4.31	2.16	1.08
Lens Epithelial Cells, donor2	11609-120I7	117.52	29.29	3.81	11.65	2.31	6.00
Lens Epithelial Cells, donor3	11690-122I7	55.50	9.38	2.12	2.32	1.72	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	19.68	4.03	1.19	1.42	0.83	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.07	3.07	0.56	0.56	1.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.90	3.78	0.94	1.10	1.26	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.06	2.69	2.69	1.08	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	18.28	1.89	2.52	1.58	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.24	2.91	0.75	1.51	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.29	3.28	2.46	0.82	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.39	3.03	1.26	1.52	0.76	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.42	2.53	0.70	0.99	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.87	2.77	0.40	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.03	3.88	1.16	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.00	1.67	1.11	0.74	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.51	4.53	2.09	1.05	1.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	17.89	3.82	0.72	1.67	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	11.40	3.02	0.69	0.96	0.82	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.02	3.08	1.23	0.92	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.78	2.81	0.62	0.62	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	13.54	2.93	1.10	0.55	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	21.39	3.62	1.32	1.32	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.01	2.93	1.17	1.76	1.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.21	2.74	0.00	1.24	1.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	14.06	3.88	1.94	0.97	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.12	2.96	2.15	1.08	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.62	2.42	0.91	1.51	0.76	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.77	2.07	2.59	1.04	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.03	3.56	1.26	0.63	1.47	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.98	3.61	0.60	0.90	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.76	4.13	2.75	1.38	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.05	4.33	1.32	0.75	0.19	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.18	3.71	0.95	1.27	0.85	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	1.94	1.45	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.24	2.32	0.99	0.66	3.31	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.02	2.60	1.12	1.12	0.87	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	15.18	4.07	0.74	1.11	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.58	2.47	0.99	0.99	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.31	1.37	0.27	0.55	0.55	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	17.37	3.86	2.25	0.96	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	12.48	3.65	1.22	2.74	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.80	2.24	1.82	0.98	0.98	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	18.49	2.13	1.07	1.42	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	1.45	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.69	2.33	1.09	0.62	0.93	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.11	3.22	0.72	0.00	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.80	2.61	2.29	1.31	0.98	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.65	2.59	0.47	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.81	4.08	1.49	0.50	1.24	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.53	2.31	0.51	0.00	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	2.39	0.90	0.60	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	6.80	2.27	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.11	1.53	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	2.97	2.23	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.54	5.08	1.27	1.69	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.07	2.81	0.70	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	13.08	7.47	0.93	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	3.61	2.06	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.68	3.17	0.90	0.45	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.45	3.78	0.87	2.04	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.81	3.60	0.45	1.80	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	21.54	4.20	1.08	1.35	1.22	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.81	2.57	0.00	1.03	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	20.82	3.18	0.00	0.71	1.06	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.99	1.33	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.87	2.04	1.02	0.51	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	20.81	2.67	0.53	0.27	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	21.54	4.16	0.94	0.57	1.13	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	13.50	4.91	0.61	0.61	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	25.28	2.45	0.00	0.00	3.26	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	17.70	3.54	0.62	1.46	0.83	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.62	4.20	0.28	0.84	1.12	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	13.39	6.18	0.00	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	20.61	4.06	0.00	1.74	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.93	6.88	0.90	0.90	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	25.45	5.53	2.21	0.55	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	26.16	3.53	0.35	1.06	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	24.71	4.06	1.11	0.74	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	5.76	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	20.72	5.37	1.15	0.77	3.07	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.25	1.70	0.00	0.57	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	3.28	2.46	0.00	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.95	3.62	1.36	0.00	1.81	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.83	4.31	0.72	0.00	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	21.66	2.24	0.75	2.99	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.95	3.34	2.23	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.09	6.46	0.86	1.72	1.29	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	22.26	5.14	0.86	2.57	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	17.99	4.33	0.33	0.33	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.31	7.84	1.21	1.21	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	22.75	3.55	1.42	1.42	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.28	2.06	0.34	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.54	4.83	1.61	0.54	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	21.55	3.37	1.35	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	21.11	5.19	0.37	0.37	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	3.49	2.33	1.16	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	17.98	1.06	3.17	0.00	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.81	4.40	1.20	0.40	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.08	3.63	0.00	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	18.40	1.53	0.00	0.77	2.30	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	2.47	0.49	0.00	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	8.47	0.94	0.00	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.10	3.52	0.00	0.50	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	23.43	3.60	0.90	0.90	0.90	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	1.72	0.00	1.72	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	18.26	4.01	0.45	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	19.55	3.13	0.78	0.39	1.96	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.11	2.64	1.98	0.66	5.28	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	20.24	2.59	1.04	0.52	2.08	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.13	3.94	1.31	0.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.89	5.03	1.12	0.56	2.24	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	20.76	2.65	1.77	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.51	3.47	0.39	1.54	1.54	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	21.27	4.05	0.51	1.01	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	15.38	3.36	0.00	0.48	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	26.24	4.37	0.80	0.40	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.74	3.65	2.43	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.83	2.08	1.38	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.08	5.32	0.76	1.14	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	23.24	5.16	1.03	1.55	1.55	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	23.58	5.44	1.21	1.21	1.81	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	22.50	4.44	0.63	0.95	2.54	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	30.92	4.26	1.07	0.53	3.20	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	28.73	5.17	1.72	0.00	2.30	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	31.37	2.57	1.03	0.51	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	32.54	2.83	0.00	1.41	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.32	5.67	0.00	0.00	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	24.96	4.99	1.66	1.25	1.25	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	26.62	6.26	1.57	0.00	4.70	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	35.49	3.34	1.67	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	29.27	4.65	2.32	0.93	2.79	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	27.43	1.34	0.67	0.67	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	33.68	5.88	2.67	1.07	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	24.65	5.66	0.81	1.21	2.02	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	27.53	6.42	1.84	0.92	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	41.79	4.45	0.89	0.00	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	37.04	5.70	2.85	2.28	2.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	25.31	3.83	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	46.51	3.28	2.19	1.64	2.74	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.84	4.90	2.67	2.67	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	45.23	6.50	1.30	1.82	2.34	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	44.43	2.65	1.33	0.66	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	68.59	12.47	4.16	0.00	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	52.88	2.51	1.82	0.91	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	49.55	4.95	0.55	0.73	0.92	0.18
Macrophage - monocyte derived, donor3	11389-118C3	94.38	8.78	0.66	3.28	0.92	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	21.77	0.53	0.53	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	32.48	6.50	1.11	0.95	2.22	0.63
Mallassez-derived cells, donor3	11930-125I4	16.96	3.47	0.69	0.69	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	26.60	3.49	0.90	0.90	0.70	0.50
Mammary Epithelial Cell, donor2	11350-117G9	13.03	1.74	0.58	0.87	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.73	1.00	1.00	0.00	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	124.06	17.63	5.42	4.75	6.10	2.03
Mast cell, donor1	11563-120D6	154.53	11.68	11.03	2.92	0.97	1.95
Mast cell, donor2	11565-120D8	5.35	0.89	7.13	0.89	0.00	0.30
Mast cell, donor3	11566-120D9	6.75	0.90	7.20	0.00	0.00	0.45
Mast cell, donor4	11567-120E1	6.38	0.35	6.91	0.00	0.35	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	12.75	0.78	4.66	0.55	0.55	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	6.42	4.09	0.58	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	51.85	4.70	9.75	1.03	1.03	0.34
Mast cell, expanded, donor8	11941-126A6	51.55	4.52	9.87	1.84	0.67	0.67
Melanocyte - dark, donor1	11502-119F8	20.00	5.17	2.09	2.39	1.29	0.80
Melanocyte - dark, donor2	11582-120F7	48.11	7.96	1.04	3.81	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	57.52	22.31	7.46	12.10	0.43	2.97
Melanocyte - light, donor1	11274-116H5	19.98	7.29	4.23	2.12	0.24	0.94
Melanocyte - light, donor2	11351-117H1	11.60	6.82	6.82	2.05	0.00	0.00
Melanocyte - light, donor3	11423-118G1	76.32	6.94	5.20	0.87	0.00	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	34.57	11.87	11.04	4.79	0.83	2.50
Melanocyte, donor2 (MC+2)	12739-135I3	18.56	13.18	4.57	7.80	0.54	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	36.16	11.25	7.50	5.62	0.80	2.95
Meningeal Cells, donor1	11493-119E8	307.30	49.50	5.58	5.33	2.23	5.95
Meningeal Cells, donor2	11573-120E7	122.80	23.77	3.96	1.32	2.64	2.64
Meningeal Cells, donor3	11654-122E7	96.82	23.72	2.93	5.95	1.14	1.71
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	78.70	8.27	2.57	2.85	2.28	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	79.80	8.15	1.21	2.92	0.30	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	123.53	2.63	1.31	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	108.58	9.16	1.31	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	41.62	8.61	1.44	0.72	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	70.10	8.26	1.91	2.54	1.27	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	52.78	3.52	0.50	0.50	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	199.76	13.84	1.98	4.18	1.54	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	78.90	8.04	2.19	3.65	2.19	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	71.61	6.55	3.07	2.86	0.61	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	174.66	8.73	1.52	1.39	1.94	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	60.59	6.69	1.12	2.97	1.49	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	238.15	17.89	1.84	7.76	3.82	2.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	26.41	6.23	0.30	1.48	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	246.55	10.25	2.56	5.12	1.28	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	41.12	3.90	2.13	2.84	0.71	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	190.14	11.88	1.88	6.25	2.19	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	66.04	7.26	0.73	2.90	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	15.11	1.06	0.53	0.27	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	7.01	2.00	0.50	1.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	22.69	2.17	0.51	0.58	0.51	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	47.26	5.40	1.35	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	89.40	8.87	2.71	0.99	2.22	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	39.75	5.01	0.29	2.06	2.94	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	89.88	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	83.38	7.44	2.79	2.17	2.48	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	33.60	2.28	0.83	1.24	1.24	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	50.95	4.63	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	79.08	9.76	3.25	2.00	1.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	31.65	6.98	1.86	0.93	2.33	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	78.85	8.33	2.64	2.24	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	29.30	4.75	1.19	0.79	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	34.21	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	70.79	4.42	2.65	1.77	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.39	4.94	0.76	1.52	2.28	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	43.42	6.58	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	78.31	5.09	0.42	1.27	1.06	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	3.68	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	69.15	8.05	2.09	2.09	1.19	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	60.97	7.53	2.51	0.75	2.26	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.72	3.80	0.48	1.19	1.90	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	28.75	8.29	1.11	0.55	2.76	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	67.46	2.76	1.15	1.38	1.15	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	21.88	2.52	0.00	0.42	1.05	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	51.98	3.06	0.82	0.61	1.43	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	54.28	5.79	0.43	0.64	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.56	2.89	0.44	0.67	1.11	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	50.59	5.48	1.75	0.22	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.22	1.01	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	28.17	3.31	1.66	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	47.56	4.62	1.63	1.09	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.35	1.18	0.88	0.59	0.88	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	16.35	3.27	0.00	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	42.29	3.84	0.48	0.96	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	16.81	0.80	0.40	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	26.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	36.54	5.01	1.00	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.77	1.31	0.44	0.00	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.09	1.28	0.64	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	16.86	2.73	0.50	0.99	0.74	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	1.39	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	2.21	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	29.74	2.05	1.03	0.34	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	0.88	0.44	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	34.80	3.20	0.71	0.00	2.49	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	37.59	3.37	0.56	0.28	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.74	0.42	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	47.20	5.24	0.58	0.00	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	52.19	6.33	0.30	0.00	0.90	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.19	0.83	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	79.43	10.16	0.92	0.92	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	10.81	0.57	1.14	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	106.12	8.71	0.69	1.52	0.97	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	93.55	5.96	0.26	0.78	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.44	1.29	1.29	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	59.07	5.08	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	93.41	6.67	0.27	1.87	0.27	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	37.12	3.59	0.00	0.60	2.39	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	79.38	8.05	0.28	1.13	0.42	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	99.06	7.33	0.00	2.23	0.32	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.34	2.21	0.22	0.00	1.55	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	65.60	7.96	0.00	0.76	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	96.60	5.68	0.85	0.85	0.85	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.46	2.70	0.74	0.25	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	65.82	7.82	0.65	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	83.21	6.47	0.88	0.88	1.18	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	50.46	3.17	0.29	0.00	2.02	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	147.96	11.95	0.41	2.47	1.24	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	109.88	10.72	0.89	2.08	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	39.21	1.78	0.00	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	107.44	10.19	2.30	2.63	0.66	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	12.62	3.16	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	111.89	7.51	2.17	2.57	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	7.45	0.00	0.00	0.93	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.39	2.25	0.38	0.00	0.38	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	91.36	6.13	1.33	1.86	2.13	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	47.95	5.20	1.02	0.79	0.34	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	43.47	6.63	2.21	2.95	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	89.77	9.89	1.83	2.20	1.10	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	38.89	10.89	1.56	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	20.84	1.60	1.07	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	7.73	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	84.83	6.06	3.03	2.02	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	29.94	4.64	0.00	1.26	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	1.51	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	41.58	5.39	3.23	1.94	1.51	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	88.32	4.70	1.05	1.05	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	34.04	2.67	0.00	3.34	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.87	3.76	0.00	0.00	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	8.94	4.75	0.95	1.33	3.42	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	25.53	4.79	1.60	1.60	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	2.04	3.40	0.68	2.04	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	1.84	3.68	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	69.90	7.12	1.26	5.44	0.42	2.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	37.19	4.42	1.16	0.93	1.39	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	78.10	10.27	0.81	2.43	1.08	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	95.03	10.30	3.15	4.63	1.68	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	92.32	4.96	1.49	1.49	0.50	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	44.93	4.87	1.35	2.17	1.62	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	105.63	4.99	1.36	4.08	2.27	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	98.14	9.47	1.14	4.25	0.82	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	117.74	10.02	0.73	4.56	1.46	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	59.94	4.77	0.00	2.12	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	83.44	1.80	0.60	1.20	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.63	3.61	0.33	1.31	3.94	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	112.37	5.37	0.98	3.09	1.46	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	215.19	13.41	1.94	6.53	2.12	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	73.84	4.22	0.70	0.70	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	81.37	2.76	1.38	3.22	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	52.06	6.43	0.32	1.61	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	37.59	4.48	0.34	1.03	3.45	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	0.00	0.00	2.53	10.11	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	206.97	10.25	2.45	6.24	1.78	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	39.80	4.66	0.00	2.54	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	40.35	2.14	1.42	0.95	2.14	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	72.54	6.01	1.72	3.86	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	9.03	0.00	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	79.97	6.66	1.67	1.00	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	114.52	6.31	1.80	3.16	1.80	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	61.50	1.98	0.79	1.98	1.59	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	91.01	8.36	1.86	0.93	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	50.70	3.78	1.14	4.16	1.51	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	69.09	4.56	1.63	2.61	1.30	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	35.73	3.92	1.74	3.49	0.87	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	83.67	9.50	2.26	1.81	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	104.95	7.06	0.88	3.53	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	163.55	3.99	0.66	3.99	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	70.93	5.46	1.98	2.48	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	76.57	5.74	0.77	2.30	1.91	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.36	4.23	1.81	1.21	2.12	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	131.73	6.41	1.77	2.43	1.77	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	149.76	6.10	0.68	2.03	3.39	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	0.00	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.22	1.83	3.66	5.49	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	57.28	4.72	2.83	2.52	0.94	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.17	0.91	3.33	0.91	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	57.75	4.75	3.16	3.96	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	30.61	10.20	1.13	0.00	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	0.00	15.17	0.00
Myoblast, donor1	11241-116D8	30.56	2.98	1.37	1.24	2.24	0.25
Myoblast, donor2	11322-117D8	47.18	4.79	1.53	1.34	1.92	0.58
Myoblast, donor3	11398-118D3	43.22	6.22	0.34	2.19	1.85	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.97	2.63	3.50	0.73	0.73	0.15
Natural Killer Cells, donor1	11230-116C6	1.85	0.00	0.92	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	2.11	0.30	0.60	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	3.50	0.18	1.29	0.55	0.37	0.00
Neural stem cells, donor1	11275-116H6	34.84	11.61	1.81	6.90	1.09	5.81
Neural stem cells, donor2	11352-117H2	48.14	13.48	3.85	7.70	3.85	3.85
Neurons, donor1	11494-119E9	36.41	13.65	1.14	3.41	3.41	3.41
Neurons, donor2	11574-120E8	28.40	11.89	4.40	11.23	1.10	2.86
Neurons, donor3	11655-122E8	18.91	4.93	4.11	4.93	6.58	1.64
Neutrophils, donor1	11233-116C9	0.00	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.61	1.22	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	47.02	5.22	0.95	2.49	1.31	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	108.10	5.21	0.33	2.28	1.30	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	60.57	7.82	1.20	1.20	2.61	0.40
Olfactory epithelial cells, donor1	11933-125I7	14.04	2.62	1.51	0.41	0.00	0.41
Olfactory epithelial cells, donor2	11934-125I8	11.43	2.17	1.30	0.58	0.72	0.14
Olfactory epithelial cells, donor3	11935-125I9	17.37	2.04	1.59	1.59	1.36	0.11
Olfactory epithelial cells, donor4	11936-126A1	25.91	2.82	2.82	1.36	0.29	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	98.10	8.43	3.01	2.41	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	17.65	1.49	0.64	0.43	0.64	0.21
Osteoblast - differentiated, donor2	11353-117H3	110.88	3.43	1.14	2.29	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	161.38	3.72	1.86	2.48	1.24	0.62
Osteoblast, donor1	11277-116H8	57.07	8.21	0.78	3.13	2.15	0.59
Osteoblast, donor2	11354-117H4	21.77	2.81	2.11	1.40	0.00	1.40
Osteoblast, donor3	11426-118G4	30.75	4.62	1.60	2.84	1.60	0.89
Pancreatic stromal cells, donor1	11249-116E7	79.18	6.99	0.93	2.02	2.11	0.17
Pericytes, donor1	11491-119E6	275.94	22.70	2.89	3.45	2.78	5.67
Pericytes, donor2	11571-120E5	120.20	13.13	3.62	2.94	3.62	2.26
Pericytes, donor3	11652-122E5	93.59	7.53	1.42	2.44	0.41	0.81
Perineurial Cells, donor1	11499-119F5	152.47	17.29	3.28	5.09	1.13	2.94
Perineurial Cells, donor2	11579-120F4	50.33	8.00	1.38	2.85	0.37	1.20
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	7.33	0.96	1.27	0.32	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	3.43	0.49	0.73	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	7.64	1.81	1.29	0.13	0.13	0.13
Placental Epithelial Cells, donor1	11278-116H9	0.48	0.00	0.00	0.00	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	22.18	5.54	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	18.65	2.55	1.96	0.59	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	33.86	6.01	1.58	1.27	1.90	0.63
Preadipocyte - breast, donor1	11467-119B9	78.04	3.19	0.75	1.50	1.50	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	45.16	4.70	3.26	0.91	0.52	0.00
Preadipocyte - breast, donor2	11328-117E5	48.41	4.05	0.45	1.35	0.90	0.00
Preadipocyte - omental, donor1	11468-119C1	118.28	7.78	1.17	3.52	2.56	0.75
Preadipocyte - omental, donor2	11329-117E6	48.01	3.93	1.31	0.87	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	53.57	6.30	2.44	1.72	1.72	0.72
Preadipocyte - perirenal, donor1	11469-119C2	55.12	1.97	0.00	1.97	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	15.97	1.84	0.92	0.00	1.23	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	13.46	3.01	0.71	0.71	1.42	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	16.01	2.04	1.19	0.68	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	13.79	2.79	1.12	0.65	1.02	0.09
Preadipocyte - visceral, donor2	11357-117H7	15.65	1.38	0.92	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	5.96	1.04	0.10	0.21	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	101.83	14.63	3.47	4.53	1.21	3.47
Prostate Epithelial Cells, donor2	11331-117E8	23.43	2.03	1.35	0.68	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	1.96	0.06	1.53	0.00	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	27.34	3.30	0.80	2.05	0.68	0.57
Prostate Stromal Cells, donor2	11332-117E9	37.83	5.38	2.15	1.97	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	51.83	4.59	0.63	2.29	1.46	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	85.04	11.31	5.84	3.65	1.46	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	68.55	10.33	6.17	2.01	0.97	1.80
Renal Epithelial Cells, donor1	11517-119H5	59.35	5.07	1.01	5.58	3.04	1.52
Renal Epithelial Cells, donor2	11597-120H4	33.43	7.82	1.42	2.85	1.42	1.42
Renal Epithelial Cells, donor3	11678-122H4	60.55	10.90	6.14	5.29	1.38	2.01
Renal Glomerular Endothelial Cells, donor1	11514-119H2	24.51	6.13	2.72	2.04	2.72	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	33.96	6.74	4.31	0.94	1.35	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	33.52	5.55	2.22	2.44	1.55	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	3.99	2.00	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	74.83	9.90	2.42	4.18	3.52	2.20
Renal Mesangial Cells, donor2	11598-120H5	65.83	16.93	6.90	5.02	3.76	1.88
Renal Mesangial Cells, donor3	11679-122H5	33.84	6.10	3.33	3.33	1.94	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	58.78	8.86	6.71	2.68	2.42	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	39.64	7.17	4.22	0.84	0.84	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.42	11.57	3.09	4.44	1.74	2.12
Retinal Pigment Epithelial Cells, donor0	11215-116A9	202.50	21.52	4.41	9.07	3.63	4.93
Retinal Pigment Epithelial Cells, donor1	11528-119I7	82.43	16.20	4.26	6.25	1.71	3.98
Retinal Pigment Epithelial Cells, donor2	11608-120I6	72.04	12.35	1.03	5.15	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	33.62	7.78	1.25	3.51	1.76	4.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	98.09	4.28	2.00	1.87	1.07	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	28.59	11.61	1.79	2.68	2.68	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	27.52	7.15	0.55	3.85	2.75	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	5.80	2.90	4.06	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	43.30	19.11	3.77	4.55	3.77	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	54.72	16.48	3.38	9.14	3.67	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	68.37	23.31	4.80	10.48	4.13	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	37.46	18.73	3.72	5.95	3.85	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	46.04	19.81	4.20	9.67	2.80	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	60.09	22.19	5.55	11.56	3.93	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	46.82	17.25	3.83	2.88	2.46	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	40.24	19.82	4.08	6.50	2.12	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	55.55	18.99	3.05	7.35	3.23	3.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	50.21	16.07	4.88	2.58	2.44	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	42.50	19.64	2.68	8.59	2.90	3.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	50.23	19.25	4.65	6.86	3.98	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	40.34	15.87	4.78	3.25	3.25	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	41.83	18.26	3.35	8.11	3.82	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	62.57	25.74	4.51	13.91	3.76	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	43.13	16.06	2.92	2.52	4.11	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	39.81	15.57	2.92	8.08	3.60	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	51.75	20.05	2.67	12.60	5.73	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	42.50	17.62	3.20	3.42	2.88	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	42.61	18.22	2.80	8.13	5.05	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.93	19.82	3.93	8.37	3.42	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.38	18.23	3.46	3.28	2.73	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	44.27	16.43	4.05	7.11	4.29	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	56.95	22.70	3.90	8.87	4.84	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	52.36	13.21	4.95	3.30	3.30	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	49.21	21.03	3.17	8.13	2.98	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	53.55	24.79	3.04	8.89	5.85	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	47.28	14.72	3.53	4.77	3.11	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	38.71	20.13	4.65	7.08	3.10	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	51.39	20.89	2.92	10.24	2.72	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	46.16	17.23	4.98	3.77	3.63	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	37.29	16.18	3.41	5.62	2.38	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	50.13	19.47	3.86	7.71	3.28	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	34.90	10.66	4.47	2.24	3.09	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.90	15.77	2.33	6.58	3.43	3.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	40.39	16.75	2.79	7.88	3.28	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	40.73	16.19	3.07	2.90	3.41	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	44.68	18.94	2.81	9.47	4.14	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	46.91	18.93	5.33	6.13	5.06	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.59	15.62	6.08	3.18	5.12	1.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	45.00	21.19	4.29	8.57	5.24	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	72.76	24.99	6.05	10.68	4.64	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	48.22	19.49	5.56	3.77	4.99	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	37.03	19.21	3.84	4.54	2.45	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	37.47	9.67	5.44	7.56	3.32	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	70.98	23.25	5.51	5.14	3.92	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	41.19	20.52	6.84	6.70	4.51	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	17.64	4.87	7.30	3.04	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	57.57	22.60	4.52	3.32	3.62	2.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	43.43	21.26	7.01	7.24	2.26	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	52.42	24.26	9.88	10.18	2.70	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	39.55	16.41	6.85	3.19	3.31	2.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	39.91	12.59	7.26	9.18	1.71	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.65	8.41	6.61	3.61	2.40	2.40
Schwann Cells, donor1	11498-119F4	89.33	15.42	4.14	3.20	1.50	0.94
Schwann Cells, donor2	11578-120F3	64.65	10.21	0.00	6.80	3.40	0.00
Schwann Cells, donor3	11659-122F3	138.90	15.12	1.97	4.60	1.53	1.97
Sebocyte, donor1	11220-116B5	43.27	3.29	0.55	1.64	0.55	1.10
Sebocyte, donor2	11301-117B5	15.17	3.68	0.46	0.00	0.46	0.46
Sebocyte, donor3	11378-118B1	114.80	5.57	0.62	2.06	0.62	0.82
Sertoli Cells, donor1	11255-116F4	13.25	0.00	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	45.19	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	5.28	1.32	0.88	0.18	0.18	0.26
Skeletal Muscle Cells, donor2	11358-117H8	30.36	4.34	1.45	1.45	5.06	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.02	0.84	0.84	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	131.96	11.62	1.73	4.24	0.94	0.94
Skeletal Muscle Cells, donor5	11455-119A6	169.16	8.92	1.93	2.97	1.64	1.49
Skeletal Muscle Cells, donor6	11459-119B1	97.11	11.39	3.23	2.15	2.31	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	313.00	16.63	2.14	7.18	2.02	1.89
Skeletal Muscle Satellite Cells, donor2	11321-117D7	210.89	13.56	2.28	5.99	2.43	2.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	103.67	12.50	1.39	5.16	2.08	1.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	27.63	4.38	1.94	1.85	0.84	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	0.72	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	47.88	5.50	1.10	1.79	2.48	0.69
Skin - palm, donor1	10286-104F7	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	30.27	2.16	2.59	0.29	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	29.44	2.45	1.64	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	46.74	4.02	2.60	1.30	0.26	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	15.57	1.39	2.22	0.42	0.97	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	14.63	1.97	1.69	0.56	0.14	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	87.12	4.44	4.65	1.48	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	16.79	1.65	4.20	0.52	0.52	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.57	0.93	0.93	0.31	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	36.46	2.00	3.11	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.98	6.47	0.00	1.18	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.35	1.33	0.88	0.66	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.48	1.58	0.79	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	42.49	7.73	0.77	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	34.03	5.00	2.00	2.00	3.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	28.88	3.99	1.73	1.06	0.80	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	31.03	2.66	1.33	1.11	0.66	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.93	2.18	2.30	0.26	0.26	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	461.36	29.63	2.60	8.47	0.33	3.26
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	215.29	15.95	0.89	3.84	1.48	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	204.29	10.68	1.14	4.13	1.42	1.99
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	138.92	6.02	0.81	1.95	0.65	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	165.92	7.00	0.30	2.44	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.09	1.01	0.25	0.00	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.21	1.91	1.91	0.95	1.91	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	183.90	12.09	1.33	3.83	1.33	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	212.23	9.69	0.43	4.95	0.43	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	216.32	13.85	0.42	3.67	1.68	2.62
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.52	0.93	0.93	0.31	0.93	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	1.08	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.76	2.39	0.30	0.00	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	111.30	12.63	1.37	3.41	1.37	3.07
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	148.42	14.45	1.57	5.42	1.33	1.26
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.46	1.31	0.70	0.40	0.91	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	5.01	0.46	0.23	0.68	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	24.15	3.02	0.60	0.60	1.21	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	39.47	7.15	1.59	2.91	1.32	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	78.83	6.39	1.73	0.40	2.00	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	86.28	4.01	0.63	1.63	0.50	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	240.22	5.33	0.76	3.80	0.51	2.28
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.97	1.06	0.60	0.15	1.21	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.75	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	18.09	1.29	6.46	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.46	2.79	1.86	0.93	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.07	0.50	1.01	1.01	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.89	1.25	1.57	0.31	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	177.88	3.24	0.59	0.88	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	133.37	11.16	2.17	3.58	1.42	1.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	167.24	5.14	2.34	4.20	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.38	1.01	0.58	0.86	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	25.75	2.55	0.76	0.76	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	23.69	3.01	1.50	1.32	0.75	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	128.98	11.46	1.26	4.47	1.68	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	140.93	12.74	1.34	3.10	1.01	1.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	72.86	6.67	0.48	0.48	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.25	2.69	1.22	0.49	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	60.32	3.31	0.44	0.00	1.33	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.82	2.63	0.88	0.29	0.88	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	82.21	5.83	1.36	2.33	0.58	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	66.64	1.85	0.53	1.59	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	0.74	0.37	0.00	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	27.31	1.80	0.72	0.36	3.23	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	42.02	1.99	1.14	1.70	0.85	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.94	3.94	0.00	2.36	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	1.52	0.76	0.25	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	14.77	0.40	0.00	0.40	1.20	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	59.36	2.93	1.25	1.67	0.84	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	150.34	2.75	0.92	1.83	0.92	0.00
Synoviocyte, donor1	11291-117A4	8.42	1.51	0.34	0.17	0.34	0.00
Synoviocyte, donor2	11368-117I9	14.25	1.34	0.50	0.84	2.01	0.00
Synoviocyte, donor3	11440-118H9	10.50	0.89	0.67	0.00	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	136.86	18.58	1.43	6.43	1.43	2.14
Trabecular Meshwork Cells, donor2	11612-122A1	130.81	9.91	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	80.35	9.03	2.32	4.40	0.93	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	32.83	4.23	2.08	1.15	0.29	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	30.93	2.71	1.55	0.39	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	25.77	2.86	1.72	0.57	0.57	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	100.02	3.57	2.21	2.21	0.37	0.25
Urethra, donor2	10319-105A4	14.39	3.60	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	36.13	2.92	2.13	0.27	0.53	0.27
Urothelial Cells, donor2	11600-120H7	19.63	2.40	2.40	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	13.29	2.29	0.46	0.23	0.46	0.00
Urothelial cells, donor0	11216-116B1	20.51	1.11	3.34	0.89	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	5.34	0.89	0.89	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	2.86	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	2.74	0.00	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	4.48	0.34	0.69	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	2.91	0.00	1.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	3.12	0.00	2.08	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1.84	0.00	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.91	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	56.13	11.23	3.95	6.04	2.47	4.56
Wilms' tumor cell line:HFWT	10597-108E3	14.96	7.92	9.68	1.76	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.06	4.47	1.68	0.84	0.56	0.28
achilles tendon, donor2	10292-104G4	14.47	2.07	2.07	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	53.29	6.88	7.39	1.27	2.80	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	38.54	16.02	3.48	3.71	0.00	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	9.50	2.26	3.68	1.42	0.00	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	32.11	7.07	8.16	1.90	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	32.04	13.49	3.37	3.37	0.28	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	14.38	2.54	2.75	0.63	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	98.27	15.79	3.54	4.08	4.36	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	37.89	12.78	4.85	1.32	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	58.40	14.70	7.76	7.35	1.63	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	18.64	2.72	2.33	1.55	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2.21	1.29	0.00	0.18	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	101.41	19.50	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	16.03	2.32	2.32	1.63	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	8.80	1.55	0.26	0.78	0.26	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	19.58	4.38	2.63	1.75	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	57.17	8.83	0.46	2.32	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	112.68	19.33	0.82	7.40	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	49.42	9.82	2.15	3.68	0.31	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.03	5.55	1.71	1.71	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	29.12	8.49	0.30	2.43	1.52	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	25.27	8.42	1.93	3.37	1.20	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	47.44	9.36	2.00	1.56	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	82.72	10.34	3.34	2.33	0.67	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	1.86	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	88.89	12.05	10.55	1.13	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	57.13	10.03	7.85	6.54	0.44	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	18.74	13.12	9.37	1.87	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	0.00	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	12.72	2.33	0.78	0.78	0.31	0.16
adipose, donor1	10184-103D4	19.35	14.66	4.10	3.52	11.14	1.76
adipose, donor2	10185-103D5	9.73	2.43	4.46	4.46	1.62	2.43
adipose, donor3	10186-103D6	20.15	6.81	6.26	3.54	5.17	3.54
adipose, donor4	10187-103D7	19.94	6.07	5.20	2.60	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	54.76	8.05	28.41	5.37	4.10	1.74
adrenal gland, adult, pool1	10081-102A9	130.96	0.00	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	12.01	2.67	4.00	0.80	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	18.58	8.93	6.07	3.22	0.71	1.43
amniotic membrane cells, donor1	12235-129G3	3.25	0.70	0.23	0.00	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	1.01	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	53.36	1.19	3.56	2.37	0.00	2.37
amygdala, adult, donor10252	10151-102I7	79.89	3.04	5.47	3.24	2.03	1.42
amygdala, newborn, donor10223	10360-105E9	28.40	7.10	1.29	1.61	1.29	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	12.35	3.95	1.66	1.02	1.15	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.59	3.97	2.21	0.66	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	34.07	11.36	4.01	7.01	3.01	1.00
aorta, adult, pool1	10052-101G7	16.67	3.14	1.77	0.59	0.78	0.00
appendix, adult	10189-103D9	5.43	0.78	2.33	1.16	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	25.45	9.29	6.19	4.13	4.13	3.44
artery, adult	10190-103E1	13.59	2.72	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	62.58	19.85	8.98	13.47	3.04	4.93
b cell line:RPMI1788	10427-106D4	31.08	4.31	6.69	1.34	1.64	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	5.55	1.11	1.94	0.55	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	33.24	9.53	8.43	2.78	3.18	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	65.44	6.53	1.67	0.84	2.34	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	28.52	6.15	1.68	1.68	0.00	1.12
bladder, adult, pool1	10011-101C2	21.08	3.04	2.28	1.85	1.09	0.43
blood, adult, pool1	10053-101G8	0.00	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.13	4.28	2.57	0.00	0.00	0.00
bone marrow, adult	10192-103E3	19.57	4.05	0.67	2.02	0.00	0.00
brain, adult, donor1	10084-102B3	107.63	5.13	3.08	3.08	1.03	4.10
brain, adult, pool1	10012-101C3	102.34	5.57	3.23	3.90	1.11	2.90
brain, fetal, pool1	10085-102B4	32.06	8.01	13.36	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	10.90	3.30	2.31	0.00	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	11.73	5.49	3.12	1.37	1.75	0.75
breast, adult, donor1	10080-102A8	13.26	2.53	0.63	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	27.82	1.40	3.68	1.78	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.17	6.18	3.40	2.47	2.47	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	50.42	5.76	9.21	2.30	4.83	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.53	4.60	1.94	1.69	1.69	0.00
carcinoid cell line:NCI-H1770	10703-109H1	105.32	36.67	7.52	18.81	2.82	7.52
carcinoid cell line:NCI-H727	10735-110B6	169.32	25.05	15.86	7.44	1.42	3.83
carcinoid cell line:SK-PN-DW	10719-109I8	32.01	20.92	0.63	4.75	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	73.73	28.48	5.32	19.96	1.33	6.65
caudate nucleus - adult, donor10196	10177-103C6	94.41	3.45	2.30	3.45	5.76	1.15
caudate nucleus, adult, donor10252	10164-103B2	51.54	2.68	4.18	2.68	1.00	1.34
caudate nucleus, adult, donor10258	10379-105H1	51.96	2.29	2.29	2.29	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	28.93	2.93	1.46	2.56	1.10	2.20
cerebellum - adult, donor10196	10173-103C2	67.01	5.83	8.74	2.91	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	32.88	7.90	5.98	2.78	3.63	2.14
cerebellum, adult, pool1	10083-102B2	42.77	6.90	5.52	3.10	2.07	1.03
cerebellum, newborn, donor10223	10357-105E6	14.11	2.49	1.66	2.49	6.64	0.00
cerebral meninges, adult	10188-103D8	37.06	4.03	1.76	2.52	2.27	1.51
cerebrospinal fluid, donor2	10294-104G6	21.93	1.46	2.19	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	8.77	4.74	17.83	3.16	1.73	3.16
cervical cancer cell line:ME-180	10553-107I4	14.75	4.14	2.82	0.83	0.00	0.50
cervix, adult, pool1	10013-101C4	23.10	3.15	3.46	1.57	0.73	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	61.03	10.17	0.98	4.60	0.70	2.09
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	0.00	2.61	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.12	10.69	1.86	3.11	0.12	1.86
choriocarcinoma cell line:SCH	10785-110H2	115.70	26.12	3.20	6.41	0.37	4.93
choriocarcinoma cell line:T3M-3	10618-108G6	28.22	9.96	3.08	1.90	0.00	1.66
chorionic membrane cells, donor1	12238-129G6	13.96	2.85	1.14	0.85	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	24.36	4.47	2.29	1.79	0.80	1.69
chorionic membrane cells, donor3	12240-129G8	9.89	2.75	0.00	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	32.31	10.10	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	20.17	5.76	2.31	1.15	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	85.74	14.15	6.97	3.80	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	534.92	27.73	24.14	8.99	3.85	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	554.63	25.64	28.54	12.09	2.90	2.66
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	454.25	24.64	17.71	11.20	4.48	3.87
chronic myelogenous leukemia cell line:K562	10454-106G4	35.92	9.72	11.19	2.94	0.00	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	112.59	21.37	8.08	5.99	0.00	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	22.17	2.51	6.40	1.14	2.51	0.91
clear cell carcinoma cell line:TEN	10636-108I6	40.77	9.72	2.43	4.16	2.78	0.35
colon carcinoma cell line:CACO-2	10513-107D9	65.16	15.92	2.56	4.76	2.20	1.28
colon carcinoma cell line:COLO-320	10420-106C6	41.05	23.57	14.06	11.02	11.40	1.14
colon, adult, donor1	10082-102B1	9.52	1.19	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	16.45	1.29	1.18	0.71	0.12	0.12
colon, fetal, donor1	10070-101I7	1.24	0.00	0.62	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	36.67	22.92	22.92	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	84.56	20.40	10.62	9.35	4.67	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	99.01	28.07	9.51	9.06	3.92	3.62
cord blood derived cell line:COBL-a untreated	10449-106F8	117.89	27.22	10.86	11.14	5.08	3.24
corpus callosum, adult, pool1	10042-101F6	240.47	8.62	4.53	6.41	3.87	4.98
cruciate ligament, donor2	10295-104G7	9.73	0.00	0.81	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	8.83	0.00	4.82	0.00	1.61	0.00
diencephalon, adult	10193-103E4	61.68	1.68	2.40	0.72	1.92	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	14.92	2.53	1.15	1.15	0.69	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	19.23	4.36	3.59	2.05	1.54	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	70.77	8.91	5.06	2.17	1.44	0.96
ductus deferens, adult	10196-103E7	49.83	3.49	2.99	1.99	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	1.44	0.00	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	6.62	0.74	1.47	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	28.16	5.29	0.74	1.90	0.58	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.10	8.22	4.22	3.55	0.00	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	39.69	16.19	3.30	7.31	0.86	1.58
embryonic pancreas cell line:1B2C6	10604-108F1	6.78	0.62	5.55	1.23	2.47	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	9.38	2.12	4.54	0.61	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	11.42	0.31	5.25	0.93	2.16	0.00
embryonic pancreas cell line:2C6	10603-108E9	5.25	1.31	5.25	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	4.02	3.02	1.34	1.34	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	13.77	1.81	6.52	0.36	1.27	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	2.25	0.48	0.48	0.16	0.48	0.00
epidermoid carcinoma cell line:A431	10426-106D3	16.12	2.22	0.44	0.78	0.67	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	57.30	17.60	15.84	7.26	4.84	1.87
epididymis, adult	10197-103E8	9.21	1.05	1.05	0.21	1.05	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.06	5.32	4.61	1.95	1.95	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	58.99	8.26	1.18	6.29	1.18	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	118.34	32.24	11.27	14.94	8.78	4.72
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	145.76	40.65	15.26	16.04	9.65	5.12
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	125.36	30.02	11.54	17.14	8.63	5.04
esophagus, adult, pool1	10015-101C6	9.03	1.27	1.06	0.32	0.21	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	8.52	1.38	4.13	1.75	2.25	0.50
eye - muscle inferior rectus, donor1	10272-104E2	24.15	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	0.00	0.00	2.10	2.10	4.21
eye - muscle medial, donor2	10299-104H2	14.88	1.49	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	21.78	2.29	2.29	0.00	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	7.29	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	15.00	1.27	5.08	1.27	0.00	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	26.93	5.90	2.95	2.82	0.77	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	46.06	14.96	4.75	3.09	0.95	0.95
frontal lobe, adult, pool1	10040-101F4	106.77	7.13	3.00	4.88	2.44	3.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	50.74	16.81	6.91	9.01	1.50	4.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	2.01	0.64	3.11	0.46	0.00	0.00
gall bladder, adult	10198-103E9	23.66	2.90	2.41	1.45	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	1.07	0.00	2.15	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	2.99	0.37	1.87	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	27.25	6.13	2.32	2.96	1.06	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	18.76	3.48	7.54	0.77	0.39	0.58
gastric cancer cell line:AZ521	10549-107H9	68.86	17.71	13.44	8.85	9.02	5.90
gastric cancer cell line:GSS	10560-108A2	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	115.60	25.13	4.57	6.17	1.14	3.20
giant cell carcinoma cell line:LU65	10487-107B1	0.34	0.57	0.69	0.00	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	27.71	3.92	1.12	1.82	0.28	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	24.94	6.48	1.25	0.75	1.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	74.73	14.57	3.17	6.33	2.11	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	78.51	15.59	1.69	6.32	1.69	1.26
glioblastoma cell line:T98G	10485-107A8	45.92	12.80	3.31	6.29	3.09	2.54
glioma cell line:GI-1	10413-106B8	97.53	19.62	5.86	9.37	2.64	3.51
globus pallidus - adult, donor10196	10175-103C4	74.35	1.46	4.37	0.73	1.46	2.19
globus pallidus, adult, donor10252	10161-103A8	89.58	3.42	3.17	2.20	0.49	1.71
globus pallidus, adult, donor10258	10367-105F7	86.26	2.74	2.74	1.37	0.00	6.85
globus pallidus, newborn, donor10223	10364-105F4	62.35	1.60	2.66	4.26	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	61.18	12.24	4.89	12.24	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.60	1.60	2.24	0.32	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	12.86	3.67	4.13	0.92	0.92	1.84
hIPS +CCl2, biol_rep2	14384-156C1	15.55	1.83	7.32	0.46	0.91	1.37
hIPS +CCl2, biol_rep3	14385-156C2	11.59	3.86	9.02	0.00	0.64	3.22
hIPS, biol_rep1	14380-156B6	21.56	0.00	8.62	0.00	2.87	0.00
hIPS, biol_rep2	14381-156B7	9.60	0.69	8.92	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	86.07	4.41	2.21	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	10.06	2.87	4.60	0.57	0.29	0.00
heart - mitral valve, adult	10205-103F7	33.78	2.09	3.59	2.69	1.49	1.20
heart - pulmonic valve, adult	10206-103F8	21.96	2.88	2.88	1.31	0.78	1.05
heart - tricuspid valve, adult	10207-103F9	15.82	0.00	4.16	0.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	27.14	3.67	7.14	0.82	0.61	1.22
heart, adult, diseased, donor1	10051-101G6	10.65	1.70	1.70	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	18.63	3.22	2.53	1.61	0.00	0.23
heart, fetal, pool1	10046-101G1	19.51	6.57	7.29	5.34	0.41	1.85
hepatic mesenchymal tumor cell line:LI90	10778-110G4	38.87	3.70	2.78	0.93	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	29.73	14.27	5.95	4.76	2.38	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	111.93	19.56	2.32	7.29	2.98	3.31
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	120.89	17.36	3.40	6.43	5.34	3.03
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	120.35	22.53	4.14	8.29	3.94	3.84
hepatoma cell line:Li-7	10484-107A7	115.89	23.36	2.22	7.56	1.33	3.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	78.09	19.10	3.92	6.43	2.01	1.91
hippocampus - adult, donor10196	10169-103B7	70.97	5.68	3.79	4.73	2.84	3.79
hippocampus, adult, donor10252	10153-102I9	97.56	6.12	3.88	3.88	2.45	3.88
hippocampus, adult, donor10258	10374-105G5	52.78	2.49	3.98	1.00	2.49	4.48
hippocampus, newborn, donor10223	10363-105F3	21.85	2.47	2.82	2.11	1.76	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	18.92	6.71	11.60	2.44	2.44	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	30.43	4.91	15.51	2.16	2.36	4.12
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	30.72	7.36	15.74	2.79	1.78	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.32	16.35	9.59	6.77	3.38	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.53	11.36	11.62	7.75	2.84	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	31.13	11.01	12.53	8.73	2.66	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.36	10.22	7.30	7.01	8.47	5.84
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.34	6.25	9.26	6.03	6.25	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.61	8.34	5.84	5.00	7.51	7.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	47.83	13.02	5.92	11.13	5.92	10.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	56.09	17.52	6.27	9.48	7.39	8.20
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	51.17	14.81	8.75	11.45	2.69	8.08
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	29.42	5.48	12.05	3.60	1.25	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	21.13	2.95	12.77	0.49	1.47	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	4.36	6.11	0.87	1.75	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	44.48	22.34	12.41	10.12	1.15	11.26
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	36.63	19.62	5.23	6.11	2.18	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	26.99	16.99	9.00	7.50	7.00	6.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.88	4.52	5.27	3.20	0.94	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.64	5.46	1.82	4.55	3.18	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.84	4.39	3.45	3.45	1.57	4.70
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.84	9.47	2.61	5.55	1.96	7.84
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	21.48	9.29	2.32	5.81	1.16	6.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.63	8.67	2.99	7.47	2.09	9.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	33.99	7.57	14.23	2.96	3.51	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	29.38	9.98	16.55	2.28	1.14	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	32.66	10.21	13.07	2.04	6.53	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	37.32	15.84	6.69	5.99	3.17	5.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	42.44	14.25	12.35	7.92	1.58	5.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.37	15.13	11.20	9.38	2.72	8.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	22.75	7.76	4.14	5.17	2.07	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	32.54	5.31	8.63	6.64	7.97	6.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.91	7.44	2.57	5.64	3.59	6.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.86	11.25	5.11	7.93	2.05	8.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	29.53	7.57	2.27	8.33	5.30	6.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	26.21	11.09	3.70	3.70	4.03	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	40.81	5.31	21.98	2.66	3.38	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	22.73	6.68	11.59	4.46	3.12	5.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	27.32	7.32	17.07	4.39	1.46	5.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	52.26	21.09	11.00	4.58	1.53	6.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	13.01	0.00	3.25	19.52	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	33.09	19.19	6.95	8.60	1.65	6.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	27.36	9.30	4.38	6.02	3.83	6.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.99	6.88	4.70	6.88	4.70	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	24.56	7.12	4.27	5.69	5.69	4.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	35.80	15.51	5.97	4.77	7.16	9.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	48.75	14.49	4.74	12.73	5.82	11.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.67	7.81	2.69	4.85	5.66	6.73
immature langerhans cells, donor1	11904-125F5	0.73	0.48	0.24	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	104.48	9.56	3.31	4.73	4.16	2.84
keratoacanthoma cell line:HKA-1	10791-110H8	0.00	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	9.51	1.70	1.20	0.70	0.40	0.30
kidney, fetal, pool1	10045-101F9	17.75	2.90	4.53	1.70	0.57	0.78
large cell lung carcinoma cell line:IA-LM	10509-107D5	14.63	5.11	6.25	1.28	0.71	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	63.31	11.20	3.59	3.59	2.76	1.66
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	35.60	7.71	6.79	2.20	1.10	0.92
left atrium, adult, donor1	10079-102A7	27.24	3.27	1.63	0.54	0.00	1.09
left ventricle, adult, donor1	10078-102A6	9.10	0.00	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	13.13	5.20	2.74	3.01	0.82	1.09
leiomyoma cell line:10964C	10569-108B2	21.20	1.44	1.08	0.36	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	9.24	0.00	0.00	0.00	1.09	0.00
leiomyoma cell line:15425	10571-108B4	8.26	1.21	0.24	0.24	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	9.41	3.14	2.09	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	36.13	7.08	8.62	2.36	1.42	1.18
liposarcoma cell line:KMLS-1	10782-110G8	34.37	5.62	2.19	1.56	1.72	0.47
liposarcoma cell line:SW 872	10726-110A6	35.33	9.99	5.60	5.36	1.83	2.68
liver, adult, pool1	10018-101C9	35.82	4.05	0.97	0.97	1.94	0.16
liver, fetal, pool1	10086-102B5	157.10	4.70	4.70	1.88	1.88	2.82
locus coeruleus - adult, donor10196	10182-103D2	109.37	5.10	3.21	4.52	3.94	3.94
locus coeruleus, adult, donor10252	10165-103B3	82.49	3.14	3.32	3.32	2.03	1.48
locus coeruleus, adult, donor10258	10375-105G6	99.03	5.92	2.82	5.36	1.41	2.82
locus coeruleus, newborn, donor10223	10362-105F2	29.02	2.10	1.68	2.10	4.21	0.84
lung adenocarcinoma cell line:A549	10499-107C4	112.38	14.81	10.52	3.74	2.91	1.52
lung adenocarcinoma cell line:PC-14	10408-106B3	11.03	3.45	1.38	0.00	4.14	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.05	4.88	4.61	3.30	3.43	0.79
lung, adult, pool1	10019-101D1	53.87	6.26	3.31	2.01	0.59	0.24
lung, fetal, donor1	10068-101I5	13.13	1.14	4.85	0.29	1.43	0.29
lung, right lower lobe, adult, donor1	10075-102A3	9.62	0.00	3.67	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	31.24	1.89	1.42	0.95	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	0.22	0.44	0.44	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.60	4.53	3.17	2.72	1.96	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	5.10	3.40	2.55	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	128.76	2.22	0.00	1.33	1.78	0.44
mature adipocyte, donor2	12232-129F9	63.71	4.15	0.21	0.83	0.42	0.00
mature adipocyte, donor3	12233-129G1	72.54	2.13	0.00	0.71	0.95	0.00
mature adipocyte, donor4	12234-129G2	332.71	4.74	0.79	2.37	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	6.91	3.57	4.53	1.19	1.19	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	46.25	5.64	2.26	4.51	4.51	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	76.69	5.15	3.86	0.92	2.57	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	47.34	4.77	3.18	1.59	1.27	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	8.10	3.84	2.56	1.71	2.99	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	60.75	4.56	3.04	3.04	4.39	2.53
medial temporal gyrus, adult, donor10252	10156-103A3	94.86	5.09	2.33	1.27	3.18	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	0.00	1.93	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	19.74	4.31	4.31	3.59	1.79	1.44
medulla oblongata - adult, donor10196	10174-103C3	107.73	7.79	3.89	3.24	4.54	1.95
medulla oblongata, adult, donor10252	10155-103A2	70.28	4.02	4.18	2.63	2.17	1.70
medulla oblongata, adult, pool1	10038-101F2	147.17	6.69	4.16	4.98	3.75	3.35
medulla oblongata, newborn, donor10223	10361-105F1	77.42	3.82	1.74	3.47	2.43	1.04
medulloblastoma cell line:D283 Med	10838-111E1	42.51	27.46	7.75	9.96	0.00	3.10
medulloblastoma cell line:ONS-76	10759-110E3	35.83	9.17	2.57	4.52	0.49	0.98
melanoma cell line:COLO 679	10514-107E1	11.36	1.58	2.73	1.72	1.15	0.57
melanoma cell line:G-361	10465-106H6	5.97	1.90	2.44	2.71	1.36	0.81
meningioma cell line:HKBMM	10691-109F7	2.71	0.54	0.90	0.18	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	53.75	38.77	8.81	18.50	3.52	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	33.44	19.44	6.48	10.63	3.63	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	28.23	5.06	1.07	1.84	3.07	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	51.99	5.64	1.64	1.64	2.73	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.22	2.90	1.24	0.00	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	98.61	8.57	0.56	2.11	2.11	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	135.57	8.86	0.58	2.31	1.73	1.54
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	39.56	4.86	0.00	0.00	4.16	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	105.38	7.21	2.23	1.20	2.23	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	81.78	6.44	1.61	1.50	1.96	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	47.09	6.76	1.72	1.46	1.06	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	45.24	4.59	1.22	2.43	0.41	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	43.67	5.69	2.13	1.71	1.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	277.98	18.44	3.29	6.26	0.66	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	47.18	7.47	1.11	2.08	1.66	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.53	5.24	2.09	0.35	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	27.56	3.27	1.22	0.20	1.22	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	36.66	5.39	0.72	2.16	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	67.86	9.83	0.62	1.55	1.24	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.30	1.37	0.68	0.68	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.56	2.10	1.68	0.42	2.52	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	40.50	6.87	1.34	1.20	1.34	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	105.39	12.69	2.10	3.06	1.58	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	81.73	15.46	1.84	2.21	1.47	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	28.04	3.43	0.57	1.14	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	49.68	17.26	2.95	5.05	1.26	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	27.40	1.37	0.91	0.46	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.86	1.53	0.51	1.28	2.81	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	35.34	3.14	1.05	1.57	1.31	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	38.20	2.16	1.23	0.92	1.23	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	29.18	2.82	1.18	0.94	1.65	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	32.83	3.05	2.03	1.69	3.72	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	37.73	3.14	1.57	1.96	1.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	30.12	1.85	1.39	3.24	2.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	42.40	2.88	2.31	1.15	4.33	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	43.50	2.45	1.56	0.89	3.12	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	42.06	5.77	1.20	0.72	2.40	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	40.33	5.13	2.20	2.20	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	34.57	2.35	1.34	0.34	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	38.89	2.87	0.82	0.82	2.46	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	41.24	1.72	0.43	0.86	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	0.00	2.73	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	37.03	4.55	1.95	1.62	2.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	40.74	0.00	2.91	1.45	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	44.78	1.60	2.67	1.07	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	55.61	4.09	0.82	1.64	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	45.87	1.94	1.94	0.78	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	50.37	4.20	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	56.63	1.99	0.99	0.99	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	41.51	1.78	0.59	1.78	1.19	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	62.14	3.66	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	65.24	3.80	0.63	0.00	3.17	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	81.40	3.10	2.07	0.69	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	70.92	2.15	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	0.00	0.00	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	37.08	2.44	1.22	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.93	3.18	0.79	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	32.42	1.77	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	31.48	1.56	1.87	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	130.09	2.37	3.55	3.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	133.54	7.70	2.57	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	159.71	3.44	2.07	4.13	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1075.71	7.42	0.49	5.94	0.00	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	844.49	8.97	1.12	3.36	0.00	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1014.52	10.81	0.00	3.82	0.64	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2064.48	9.67	0.00	3.63	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2099.91	10.90	0.00	8.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1977.88	10.14	1.27	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	882.41	15.17	0.61	3.03	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	953.50	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	851.69	12.36	0.00	0.82	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	619.49	3.57	0.99	1.59	0.20	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	637.63	2.60	0.32	3.57	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	658.03	7.13	0.00	1.02	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	3.09	3.09	1.55	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	69.45	8.98	6.38	2.13	2.36	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	82.48	8.57	1.16	3.71	0.23	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	8.55	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.47	2.98	0.31	0.31	0.51	0.31
mesothelioma cell line:Mero-25	10850-111F4	32.00	7.49	1.59	1.13	0.00	0.91
mesothelioma cell line:Mero-41	10851-111F5	14.91	3.67	1.22	1.71	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	7.75	2.21	1.77	0.66	1.77	0.00
mesothelioma cell line:Mero-82	10853-111F7	18.13	6.57	1.84	2.89	0.53	0.26
mesothelioma cell line:Mero-83	10854-111F8	34.55	5.79	2.55	2.21	0.00	1.02
mesothelioma cell line:Mero-84	10855-111F9	51.06	9.35	0.51	1.26	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	46.17	8.07	1.24	2.90	0.83	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	69.57	12.75	2.65	2.48	1.99	1.82
mesothelioma cell line:NCI-H226	10846-111E9	46.51	5.79	0.90	1.45	1.99	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	55.00	7.00	2.05	7.00	2.73	0.51
mesothelioma cell line:NCI-H28	10845-111E8	7.38	2.04	2.29	1.02	0.51	0.00
mesothelioma cell line:No36	10857-111G2	128.52	19.57	2.94	9.79	0.33	5.55
mesothelioma cell line:ONE58	10858-111G3	173.95	19.51	4.34	5.15	0.27	1.63
migratory langerhans cells, donor1	11901-125F2	7.48	1.54	1.34	0.38	0.77	0.19
migratory langerhans cells, donor2	11902-125F3	13.43	1.47	1.83	0.49	0.49	0.49
migratory langerhans cells, donor3	11903-125F4	6.10	1.79	1.44	0.36	0.18	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.99	5.88	3.26	2.29	0.33	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.64	13.56	1.70	4.87	0.64	4.66
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	1.61	0.23	0.46	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.54	3.81	7.99	0.38	2.28	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	32.52	8.32	3.33	4.80	0.00	0.37
myeloma cell line:PCM6	10474-106I6	39.93	2.17	1.38	0.99	0.40	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	62.90	7.61	10.15	2.03	2.03	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	45.31	8.43	2.55	4.32	1.77	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.04	2.12	3.79	0.45	0.56	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	13.09	2.35	1.84	0.29	1.03	0.15
nasal epithelial cells, donor2	12227-129F4	12.70	1.66	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	75.23	44.86	18.63	27.84	2.99	8.05
neuroblastoma cell line:NB-1	10539-107G8	95.97	41.72	14.59	18.52	1.68	9.35
neuroblastoma cell line:NBsusSR	10607-108F4	106.92	39.86	3.59	13.92	1.69	2.95
neuroblastoma cell line:NH-12	10555-107I6	46.22	25.34	22.55	8.94	0.00	3.35
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	109.12	44.12	3.32	9.73	1.19	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	175.80	39.60	2.38	11.88	0.48	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	58.97	32.40	2.01	16.70	0.40	3.02
neuroepithelioma cell line:SK-N-MC	10728-110A8	117.62	76.93	9.54	8.90	1.27	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	7.72	1.60	1.86	0.27	0.80	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	61.22	15.90	8.12	3.21	0.85	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.01	6.40	2.40	3.20	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.05	2.24	2.56	1.92	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	18.92	5.52	1.58	1.58	0.26	0.53
nucleus accumbens, adult, pool1	10037-101F1	99.27	4.41	2.81	3.47	1.69	3.09
occipital cortex - adult, donor10196	10172-103C1	57.69	4.12	6.18	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	82.92	5.64	3.49	1.34	3.49	0.54
occipital cortex, newborn, donor10223	10355-105E4	16.74	3.64	5.46	2.91	1.09	1.09
occipital lobe, adult, donor1	10076-102A4	66.12	6.56	1.84	2.62	2.10	2.10
occipital lobe, fetal, donor1	10073-102A1	39.48	9.01	13.30	9.44	2.57	2.57
occipital pole, adult, pool1	10036-101E9	77.34	6.62	2.44	3.63	1.58	2.13
olfactory region, adult	10195-103E6	93.23	5.16	3.44	3.06	2.87	3.25
optic nerve, donor1	10277-104E7	42.02	8.00	8.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	119.72	20.39	6.04	2.05	5.81	1.37
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	35.03	5.36	8.79	2.47	2.47	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	5.59	1.19	0.51	0.17	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	10.97	5.43	2.54	0.81	1.39	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	13.23	2.94	0.59	0.00	0.88	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	36.44	13.08	18.69	5.61	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	241.54	46.87	4.88	14.00	1.27	5.94
ovary, adult, pool1	10020-101D2	72.94	6.11	4.98	3.93	0.44	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	9.53	1.47	1.10	0.92	0.18	0.00
pancreas, adult, donor1	10049-101G4	2.82	0.94	4.70	0.94	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	40.25	18.45	3.07	9.50	0.00	4.19
papillary adenocarcinoma cell line:8505C	10437-106E5	36.11	13.46	3.92	3.92	1.53	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	6.79	1.99	1.49	0.33	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	98.29	5.77	3.84	3.20	2.56	2.84
parietal cortex, adult, donor10258	10373-105G4	27.89	2.20	0.00	0.73	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	66.77	2.82	0.00	3.76	5.64	0.94
parietal lobe, adult, donor10252	10157-103A4	59.29	4.28	3.71	2.85	2.85	1.71
parietal lobe, adult, pool1	10034-101E7	109.71	6.70	3.44	4.32	1.76	2.29
parietal lobe, fetal, donor1	10072-101I9	42.67	12.61	15.52	8.73	2.91	5.82
parietal lobe, newborn, donor10223	10356-105E5	14.95	2.62	3.36	0.75	0.37	1.12
parotid gland, adult	10199-103F1	12.95	0.00	0.00	0.62	0.00	0.00
penis, adult	10200-103F2	16.65	1.61	0.54	1.07	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	71.03	19.71	8.00	7.07	0.74	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	23.75	6.56	1.75	2.77	1.17	0.87
pineal gland - adult, donor10196	10179-103C8	7.74	3.23	3.87	0.65	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	11.84	5.33	1.78	0.59	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	15.68	3.14	0.63	0.63	1.88	1.25
pituitary gland - adult, donor10196	10180-103C9	46.54	3.04	3.04	3.04	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	34.92	4.17	2.61	1.56	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	15.32	2.55	0.85	1.70	0.00	2.55
placenta, adult, pool1	10021-101D3	13.33	1.08	1.08	0.54	0.86	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	22.64	4.90	5.30	0.53	1.85	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	63.03	8.72	1.25	2.80	3.11	0.47
pons, adult, pool1	10033-101E6	92.87	4.30	3.18	3.36	1.98	1.38
postcentral gyrus, adult, pool1	10032-101E5	88.74	6.63	2.27	3.49	2.18	3.23
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	2.09	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	93.95	18.06	3.79	11.07	3.35	2.77
prostate cancer cell line:PC-3	10439-106E7	66.61	15.79	5.08	8.17	10.35	4.90
prostate, adult, pool1	10022-101D4	15.69	1.72	2.36	0.45	0.18	0.27
putamen, adult, donor10196	10176-103C5	59.49	4.01	2.60	3.78	1.42	1.18
putamen, adult, donor10252	10152-102I8	49.02	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	2.19	6.56	2.19	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	48.08	2.17	1.45	1.45	1.45	0.48
putamen, newborn, donor10223	10365-105F5	16.49	1.50	0.00	0.00	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	38.40	7.27	7.27	0.87	1.45	0.00
rectum, fetal, donor1	10067-101I4	13.91	2.78	0.00	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.68	8.90	1.48	1.48	4.45	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	6.63	3.31	7.04	0.41	0.83	0.00
retina, adult, pool1	10030-101E3	83.20	13.22	8.45	7.26	2.29	3.78
retinoblastoma cell line:Y79	10475-106I7	79.24	69.37	7.01	32.48	0.78	10.91
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.92	5.29	6.76	2.46	0.98	2.09
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	125.98	24.46	3.94	15.75	0.84	3.66
sacrococcigeal teratoma cell line:HTST	10695-109G2	26.52	3.79	0.76	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	21.37	2.75	0.65	1.29	0.16	0.00
salivary acinar cells, donor2	11772-123I8	8.40	0.69	0.55	0.55	0.14	0.00
salivary acinar cells, donor3	11773-123I9	6.62	0.66	1.32	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	3.43	1.72	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	77.23	13.15	3.04	4.64	3.04	1.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	72.53	12.23	1.88	4.35	2.70	0.82
seminal vesicle, adult	10201-103F3	47.09	4.23	3.17	2.12	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.65	3.40	4.62	0.49	2.43	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	34.98	5.79	4.78	1.01	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	8.03	6.02	4.01	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	49.83	7.92	1.07	2.01	1.07	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.58	6.19	2.71	0.77	3.74	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	5.67	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	8.40	0.24	0.12	0.12	0.00	0.24
skeletal muscle, fetal, donor1	10066-101I3	9.05	0.00	2.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	80.80	2.52	2.52	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	198.45	18.68	7.00	10.67	3.67	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	24.27	10.72	8.20	5.67	0.63	4.10
small cell lung carcinoma cell line:DMS 144	10841-111E4	27.18	5.78	26.21	2.12	2.12	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	55.05	26.37	3.96	12.03	2.97	4.94
small cell lung carcinoma cell line:NCI-H82	10842-111E5	73.67	50.35	10.62	7.40	1.77	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	104.60	40.10	7.41	27.02	4.36	15.47
small intestine, adult, pool1	10024-101D6	4.78	0.84	1.07	0.48	0.12	0.36
small intestine, fetal, donor1	10064-101I1	4.91	1.47	0.98	1.72	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	20.52	4.62	0.51	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	11.63	1.55	2.58	0.78	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	21.71	4.56	4.29	0.54	0.80	0.27
spinal cord - adult, donor10196	10181-103D1	67.90	3.90	3.90	0.92	2.98	2.06
spinal cord, adult, donor10252	10159-103A6	50.86	5.91	2.76	3.15	2.37	2.76
spinal cord, adult, donor10258	10369-105F9	44.97	2.08	4.15	0.00	4.84	0.69
spinal cord, fetal, donor1	10056-101H2	110.38	9.76	2.44	8.54	0.61	6.10
spinal cord, newborn, donor10223	10359-105E8	41.79	3.67	1.38	1.38	2.30	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.18	2.24	1.49	0.45	0.15	0.15
spleen, adult, pool1	10025-101D7	13.22	1.54	0.44	0.22	0.55	0.00
spleen, fetal, pool1	10044-101F8	14.70	1.59	3.26	0.87	0.40	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	17.70	2.07	1.45	1.14	2.48	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.41	1.71	2.09	0.19	1.14	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	42.28	9.44	9.78	3.84	1.05	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	8.99	1.95	0.78	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	28.59	7.88	3.60	3.60	2.70	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	34.74	5.08	2.97	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	61.77	14.38	5.08	7.19	1.27	1.69
stomach, fetal, donor1	10062-101H8	3.20	3.20	4.27	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	6.27	0.57	0.00	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	56.91	1.45	2.49	1.66	1.04	1.04
substantia nigra, adult, donor10258	10371-105G2	100.35	4.66	1.55	0.52	1.55	3.62
substantia nigra, newborn, donor10223	10358-105E7	54.41	4.24	2.83	4.24	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	63.51	14.44	3.67	2.98	1.83	0.69
temporal lobe, adult, pool1	10031-101E4	91.04	5.76	2.20	4.58	1.95	2.63
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	31.34	17.09	17.09	8.55	7.12	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	41.76	16.70	14.94	7.47	2.20	2.64
tenocyte, donor1	11763-123H8	42.94	3.49	0.00	1.05	2.09	0.70
tenocyte, donor2	11765-123I1	12.21	2.67	1.14	0.38	1.14	0.38
tenocyte, donor3	11768-123I4	10.75	1.11	1.11	0.00	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	31.78	16.15	14.28	6.97	2.38	4.42
teratocarcinoma cell line:NCR-G1	10798-110I6	98.04	20.66	7.55	8.48	2.77	4.78
teratocarcinoma cell line:PA-1	10807-111A6	37.35	8.68	5.58	2.63	1.08	3.72
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	28.44	5.84	7.62	1.90	0.25	2.29
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.15	5.29	11.35	1.89	1.13	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	9.27	2.51	6.43	0.87	0.76	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	6.19	1.30	2.28	0.00	1.30	0.00
testis, adult, pool1	10026-101D8	18.79	2.58	2.68	1.40	0.64	0.97
testis, adult, pool2	10096-102C6	23.01	1.80	2.26	0.90	1.35	1.35
thalamus - adult, donor10196	10168-103B6	118.13	1.10	3.31	4.42	6.62	3.31
thalamus, adult, donor10252	10154-103A1	111.12	2.97	5.16	2.19	1.56	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	97.00	1.54	3.08	0.00	4.62	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	75.26	2.31	3.62	2.96	1.65	2.80
thalamus, newborn, donor10223	10366-105F6	14.96	4.60	0.00	0.58	1.15	0.58
throat, adult	10209-103G2	6.49	0.25	0.75	0.25	0.25	0.00
throat, fetal, donor1	10061-101H7	5.48	0.61	0.30	0.61	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	26.43	11.33	2.78	5.56	0.20	0.60
thymus, adult, pool1	10027-101D9	7.06	3.08	4.27	0.30	0.00	0.00
thymus, fetal, pool1	10043-101F7	10.91	1.56	3.64	0.94	0.00	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	59.17	16.22	2.13	5.19	1.73	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	38.97	10.20	6.29	4.89	0.98	1.54
thyroid, adult, pool1	10028-101E1	10.45	0.75	1.21	0.28	0.75	0.47
thyroid, fetal, donor1	10060-101H6	3.69	0.79	2.11	0.26	0.79	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	9.24	0.00	6.16	3.08	0.00
tongue, adult	10203-103F5	5.35	2.33	0.23	0.47	0.00	0.00
tongue, fetal, donor1	10059-101H5	3.94	0.39	0.39	0.00	0.00	0.39
tonsil, adult, pool1	10047-101G2	8.92	1.10	1.50	0.50	0.30	0.10
trachea, adult, pool1	10029-101E2	14.72	1.23	1.55	0.49	0.90	0.08
trachea, fetal, donor1	10058-101H4	9.62	0.00	1.15	0.77	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.11	2.13	0.00	0.00	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	77.41	20.47	3.95	11.65	2.53	4.46
transitional-cell carcinoma cell line:JMSU1	10492-107B6	117.36	22.88	6.74	14.26	5.64	4.86
tridermal teratoma cell line:HGRT	10694-109G1	19.03	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	4.66	1.10	1.44	0.51	0.17	0.25
umbilical cord, fetal, donor1	10057-101H3	20.87	6.26	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	16.55	1.88	5.29	0.85	1.02	0.51
uterus, fetal, donor1	10055-101H1	24.57	3.07	3.58	2.05	0.51	1.54
vagina, adult	10204-103F6	23.26	1.94	0.00	0.00	0.00	1.29
vein, adult	10191-103E2	14.25	1.10	1.32	1.10	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.10	3.20	3.74	0.53	3.74	0.27